Bristol-Myers CEO Says the Company Is in Transition
Вставка
- Опубліковано 26 вер 2024
- Bristol-Myers CEO Christopher Boerner says the company is in transition, but he's excited about the strength of recent deals and drugs in their pipeline. He speaks on "Bloomberg Markets" from San Francisco.
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: www.bloomberg.com
Connect with us on...
Twitter: / business
Facebook: / bloombergbusiness
Instagram: www.instagram....
Bmy needs a new CEO.
Un saldado desde Bogotá el mejor laboratorio que pude haber conocido
What are you doing to reduce risk for lawsuits?
Healthcare is the future in the present currently
i’m not sure this dude could pass an undergrad bio exam
How can a company brag about their pipe line items if most of them is added in their portfolio with the acquisitions of startups?
When a CEO does an interview like this, pay careful attention to his eyebrows; Eyebrows answering questions or waiting to answer questions tells alot about stress; This guy looks stressed
Good method for investing. Good luck-you'll need it.
@@Octovisuals but meanwhile stock dropped like a rock
I think he needs to go
I just bought a ton of Calls with strike price of $43 expiring first week of August; I think they will finally beat earnings for once; And if they do there is about 17% upside instantly
Why so hung up on fat people drugs??
These tv reporters are soooo clueless, they seam to be adicted to the latest news from morgan stanley and mergers...
This company is in serious problems. They are having problems launching new products and have a massively bloated middle management